StockNews.com initiated coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
Shares of XXII stock opened at $4.73 on Thursday. 22nd Century Group has a 52-week low of $3.90 and a 52-week high of $581.85. The company has a quick ratio of 0.93, a current ratio of 1.09 and a debt-to-equity ratio of 1.59. The stock has a market cap of $219.28 million, a PE ratio of -0.21 and a beta of 1.50. The business has a 50-day simple moving average of $13.03 and a 200-day simple moving average of $52.86.
22nd Century Group (NASDAQ:XXII – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($72.90) EPS for the quarter. The company had revenue of $5.95 million during the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.
Hedge Funds Weigh In On 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Further Reading
- Five stocks we like better than 22nd Century Group
- What Does a Stock Split Mean?
- Jabil’s Winning Streak Begins: Market Bottom Set, Future in Focus
- Utilities Stocks Explained – How and Why to Invest in Utilities
- High-Flying HEICO Eyes New Heights in 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Beyond Reality: Investing in AR/VR Tech for Future Gains
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.